News

North Oaks Health System Expands Specialty Care with New Clinic

North Oaks Health System Expands Specialty Care with New Clinic

North Oaks Health System Celebrates New Clinic Opening

North Oaks Health System has achieved a significant milestone by unveiling its latest addition, a five-story specialty clinic that marks a $50 million investment in healthcare. This new facility symbolizes the organization's commitment to enhancing access to specialized medical services for the community.

Facility Overview and Specialties Offered

Strategically located, the North Oaks Clinic Building 3 boasts a generous 96,000 square feet of dedicated healthcare space. This facility will house a variety of medical experts, totaling 20 healthcare providers, across nine distinct specialties such as endocrinology, ENT and allergy, urology, oncology, and pain management. The introduction of integrated services like an optical shop, blood draw lab, and a pharmacy aims to enrich the patient experience.

Importance of Modern Infrastructure

Designed by Washer Hill Lipscomb Cabaniss Architecture, LLC, this state-of-the-art building is constructed by The Lemoine Company, LLC. It is not merely an expansion but an essential step towards modernizing healthcare infrastructure. According to North Oaks President and CEO Michele K. Sutton, FACHE, this facility is a pledge to the community, affirming that quality healthcare can remain local and accessible, thus promoting future wellness.

Impact on Healthcare Jobs and Services

Over the past few years, North Oaks has significantly contributed to local employment by adding over 900 new jobs and recruiting more than 60 specialized providers. This boost in human resources also enhances their expansive services, ranging from cardiothoracic surgery to neurology and trauma surgery. Currently, North Oaks employs approximately 3,200 healthcare professionals, helping to maintain a robust economy with an impressive annual payroll and benefits package exceeding $332 million.

Community Growth and Economic Development

The opening of Clinic Building 3 has been met with appreciation from community leaders, including Tangipahoa Parish President Robby Miller. He expressed that North Oaks serves as a significant catalyst for regional growth, dramatically impacting the local economy, creating job opportunities, and improving overall infrastructure. This investment is anticipated to generate substantial economic benefits, further strengthening the community.

Plans for Future Growth

Investment continues to funnel into North Oaks, with approximately $80 million allocated for facility upgrades within the last three years. The future looks even brighter, as North Oaks projects doubling this investment, earmarking an estimated $160 million for continued development and modernization efforts over the next three years. The commitment to growth reflects North Oaks’ vision to enhance healthcare delivery and patient-centered services.

Specialized Patient Care Services

The clinic houses essential services such as the North Oaks Oncology program, which focuses on delivering high-quality care that adheres to national standards, mitigating the stress of treatment for families and patients alike. Notably, the top floor is dedicated to hematology and oncology services, equipped with infusion bays and a dedicated pharmacy aimed at improving the convenience and quality of treatment.

Enhancing Patient Experience

North Oaks Clinic Building 3 has been meticulously designed with patient experience at the forefront. The facility is linked to other campus buildings through covered walkways, enhancing navigation and accessibility. The design also includes expanded drop-off and pick-up areas that aim to improve patient convenience, ensuring a seamless visit from start to finish.

Collaboration with Local Healthcare Providers

Leading specialists, like Dr. Georges Tanios of North Oaks Hematology & Oncology and Dr. James Parker of North Oaks Cardiology, stress the importance of the new clinic in expanding service offerings. These expansions include a new heart failure program and additional specialty services, which aim to cater to the growing healthcare needs of the community.

Looking Ahead to Expansion

As North Oaks continues to grow, they remain dedicated to meeting the healthcare needs of their community. Plans are already underway to welcome additional providers, such as Dr. Erik Rasmussen, to enhance their ENT & Allergy Clinic, and more services are on the horizon.

Frequently Asked Questions

What services will the new clinic offer?

The new clinic will offer various specialties including endocrinology, oncology, urology, and ENT care among others.

How does this expansion benefit the community?

This expansion increases access to specialized healthcare, creates jobs, and enhances overall local healthcare infrastructure.

Who are the main healthcare providers in the new clinic?

The clinic will house 20 providers across nine specialties focused on delivering comprehensive healthcare solutions.

What are the future growth plans for North Oaks?

North Oaks plans to invest approximately $160 million over the next three years to further enhance its facilities and services.

How can I find more information about North Oaks services?

You can contact North Oaks Public Relations at (985) 230-6647 or visit their website for details on services and healthcare options.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

Updated Category News Views 54

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 70

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 0

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Coastal Financial Faces Class Action Suit Over Securities

Updated Category News Views 78

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 101

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance

Updated Category News Views 53

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Continue Reading
Dizal Unveils Promising Data at ASH 2026

Updated Category News Views 72

Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...

Continue Reading
LOA Roofing's Growth Recap Taps Southstone's Backing

Updated Category News Views 107

Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 17

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation

Updated Category News Views 48

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...

Continue Reading

Top 5 Most Recently Viewed Articles

SKYX Technologies Expands Market Presence with Insider Investments

Updated Category News Views 166

SKYX Technologies' Corporate Developments SKYX Technologies, also known as SKYX (NASDAQ: SKYX), is taking significant strides in the smart technology sector. This dynamic company focuses on transforming homes and buildings into smarter, safer, and more advanced spaces. With a remarkable portfolio of over 97 issued and pending patents, SKYX aims to set a new standard in...

Continue Reading
Crinetics Pharmaceuticals Expands Workforce With Stock Options

Updated Category News Views 195

Crinetics Pharmaceuticals Enhances Employee Incentives In a recent announcement, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), based in San Diego, revealed a significant step in enhancing employee incentives and strengthening its workforce. On October 10, 2025, the company’s Compensation Committee authorized the granting of stock options and restricted stock units...

Continue Reading
Manulife Investment Management Earns Top Recognition in Sustainable Finance

Updated Category News Views 199

Manulife Investment Management Recognized for Excellence In a significant acknowledgment of its leadership in sustainable finance, Manulife Investment Management (Manulife IM) has made it to the prestigious list of IPE Real Assets' Top 50 Natural Capital Managers. This recognition comes as the firm is gearing up for robust fundraising activities, with an exciting fund...

Continue Reading
Vaxart Reports Progress and Financial Performance for Q3 2025

Updated Category News Views 213

Vaxart’s Business Progress and Financial Results Overview Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, recently provided a significant update on its business and reported its financial outcomes for the third quarter of 2025. This latest communication showcases exciting developments in their oral recombinant vaccine platform, which is designed to...

Continue Reading
Madrigal Pharmaceuticals Marks Enrollment Milestone in NASH Study

Updated Category News Views 47

Madrigal Pharmaceuticals Achieves Enrollment Milestone in NASH Study Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, has announced a significant milestone in their MAESTRO-NASH OUTCOMES clinical trial. This study evaluates the efficacy of resmetirom in patients diagnosed with...

Continue Reading